Quarterly report [Sections 13 or 15(d)]

Related Party Transactions

v3.26.3
Related Party Transactions
9 Months Ended
Sep. 30, 2026
Related Party Transactions [Abstract]  
Related Party Transactions

Note 11 – Related Party Transactions

 

2026 Series D Financing

 

On July 10, 2026, HEZBAY Holdings LLC (“HEZBAY”), a current holder of more than 5% of the Company’s common stock, purchased 500 shares of Series D Preferred Stock and Series D Warrants to purchase 95,239 shares of common stock in the Series D Financing. See Note 9 for additional information.

 

2026 Warrant Inducement

 

On July 10, 2026, the Company entered into the Inducement Letters with the Warrant Holders of its Existing Warrants. Pursuant to the Inducement Letters, the Warrant Holders agreed to exercise for cash all or a portion of their 2025 Warrants at the current exercise price of $5.25 per share in consideration for the Company’s agreement to issue New Warrants to purchase up to 499,107 shares of common stock (100% of the number of shares of common stock issued pursuant to each such exercise of 2025 Warrants), in a private placement in accordance with Section 4(a)(2) of the Securities Act. The Warrant Inducement closed on July 10, 2026. See Note 9 for additional information.

 

● HEZBAY exercised its Existing Warrants for 100,432 shares of common stock. In consideration for the exercise, the Company issued to HEZBAY New Warrants to purchase 100,433 shares of common stock.

 

● Adam K. Stern, a current holder of more than 5% of the Company’s common stock, serves as the General Partner of AKS Family Partners, LP (“AKS Family Partners”) and the Trustee of Stern Aegis Ventures LLC Defined Benefit Plan for the Benefit of Adam K. Stern (“Stern Aegis Ventures DBP”). Mr. Stern has voting and investment control over the securities held by each of AKS Family Partners and Stern Aegis Ventures DBP. AKS Family Partners exercised its 2025 Warrants for 22,980 shares of common stock. In consideration, the Company issued to AKS Family Partners New Warrants to purchase 22,981 shares of common stock. Stern Aegis Ventures DBP exercised its 2025 Warrants for 42,022 shares of common stock. In consideration, the Company issued to Stern Aegis Ventures DBP New Warrants to purchase 42,023 shares of common stock.

 

● Pembroke & Partners LLC (“Pembroke”), a current holder of more than 5% of the Company’s common stock, exercised its 2025 Warrants for 47,619 shares of common stock. In consideration, the Company issued to Pembroke & Partners LLC New Warrants to purchase 47,620 shares of common stock.

 

● Platinum Point Capital LLC, a current holder of more than 5% of the Company’s common stock, exercised its 2025 Warrants for 20,000 shares of common stock. In consideration, the Company issued to Platinum Point Capital LLC New Warrants to purchase 20,000 shares of common stock.

 

Certain holders of the Company’s Series C Convertible Preferred Stock and 2025 Warrants are related parties. During the three months ended September 30, 2026, the Company recognized deemed dividends of $3.6 million associated with the down-round adjustments to the Series C Convertible Preferred Stock and 2025 Warrants, of which $1.7 million was attributable to related parties. In addition, the Company recognized deemed dividends of $3.5 million associated with the Warrant Inducement, of which $1.7 million was attributable to related parties.

 

2025 Offering

 

On February 13, 2025, the Company entered into the February 2025 Agreement with certain investors pursuant to which the Company agreed to issue and sell, in a private placement, an aggregate of 3,300 shares of Series C Preferred Stock, initially convertible into up to 375,427 shares of common stock, with a stated value of $1,000 per share, and 2025 Warrants to purchase up to an aggregate of 200% of the shares of common stock into which the shares of Series C Preferred Stock are initially convertible, or 750,854 shares of common stock, for an offering price of $1,000 per share of Series C Preferred Stock and accompanying 2025 Warrants.

 

Pursuant to the February 2025 Agreement the Company issued and sold, in an initial closing, 1,650 shares of Series C Preferred Stock, initially convertible into up to 187,714 shares of common stock, and accompanying 2025 Warrants, initially exercisable for up to 375,427 shares of common stock, for gross proceeds of $1.65 million. On April 4, 2025, the Company obtained stockholder approval for the issuance of the Series C Preferred Stock and 2025 Warrants, as required by the rules and regulations of NYSE American, including Section 713 of the NYSE American Company Guide, and issued and sold, in a second closing, an additional 1,650 shares of Series C Preferred Stock, initially convertible into up to 187,714 shares of common stock, and accompanying 2025 Warrants, initially exercisable for up to 375,427 shares of common stock, for gross proceeds of $1.65 million.

 

● Sanitam Partners LLC, a former holder of more than 5% of the Company’s common stock, purchased 1,406 shares of Series C Preferred Stock and 2025 Warrants to purchase 319,910 shares of common stock in the Offering.

 

● Pembroke purchased 984 shares of Series C Preferred Stock and 2025 Warrants to purchase 223,891 shares of common stock in the Offering.

 

● Platinum Point purchased 410 shares of Series C Preferred Stock and 2025 Warrants to purchase 93,288 shares of common stock in the Offering.

 

● HEZBAY purchased 500 shares of Series C Preferred Stock and 2025 Warrants to purchase 113,766 shares of common stock in the Offering.